Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide

NCT03580668 · clinicaltrials.gov ↗

COMPLETED

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: B/F/TAF

Sponsor

Gilead Sciences